Biomedical Physics & Engineering Express,
Год журнала:
2024,
Номер
10(5), С. 052002 - 052002
Опубликована: Авг. 14, 2024
Abstract
Purpose
.
This
review
aims
to
highlight
current
improvements
in
microfluidic
devices
designed
for
digestive
cancer
simulation.
The
emphasizes
the
use
of
multicellular
3D
tissue
engineering
models
understand
complicated
biology
tumor
microenvironment
(TME)
and
progression.
purpose
is
develop
oncology
research
improve
patients’
lives.
Methods
analyzes
recent
on
mimicking
cancer.
It
uses
tissue-engineered
devices,
notably
organs
a
chip
(OOC),
simulate
human
organ
function
lab.
Cell
cultivation
modern
three-dimensional
hydrogel
platforms
allows
precise
geometry,
biological
components,
physiological
qualities.
novel
methodologies,
key
findings,
technical
progress
explain
this
field’s
advances.
Results
study
discusses
advances
Micro
systems
with
are
emphasized.
These
capture
complex
biochemical
gradients,
niche
variables,
dynamic
cell–cell
interactions
(TME).
reveal
stomach
progression
by
duplicating
TME.
Recent
discoveries
technology
have
improved
our
understanding
gut
biology,
as
shown
review.
Conclusion
Microfluidic
play
crucial
role
modeling
furthering
research.
could
transform
drug
development
treatment
revealing
provides
complete
summary
suggests
future
field
professionals.
review’s
major
goal
further
medical
Nature Reviews Methods Primers,
Год журнала:
2022,
Номер
2(1)
Опубликована: Дек. 1, 2022
Organoids
have
attracted
increasing
attention
because
they
are
simple
tissue-engineered
cell-based
in
vitro
models
that
recapitulate
many
aspects
of
the
complex
structure
and
function
corresponding
vivo
tissue.
They
can
be
dissected
interrogated
for
fundamental
mechanistic
studies
on
development,
regeneration,
repair
human
tissues.
also
used
diagnostics,
disease
modeling,
drug
discovery,
personalized
medicine.
derived
from
either
pluripotent
or
tissue-resident
stem
(embryonic
adult)
progenitor
differentiated
cells
healthy
diseased
tissues,
such
as
tumors.
To
date,
numerous
organoid
engineering
strategies
support
culture
growth,
proliferation,
differentiation
maturation
been
reported.
This
Primer
serves
to
highlight
rationale
underlying
selection
development
these
materials
methods
control
cellular/tissue
niche;
therefore,
engineered
organoid.
We
discuss
key
considerations
generating
robust
organoids,
those
related
cell
isolation
seeding,
matrix
soluble
factor
selection,
physical
cues
integration.
The
general
standards
data
quality,
reproducibility
deposition
within
community
is
outlined.
Lastly,
we
conclude
by
elaborating
limitations
organoids
different
applications,
priorities
coming
years.
Advanced Materials,
Год журнала:
2022,
Номер
34(15)
Опубликована: Фев. 15, 2022
Organ-
and
tissue-level
biological
functions
are
intimately
linked
to
microscale
cell-cell
interactions
the
overarching
tissue
architecture.
Together,
biofabrication
organoid
technologies
offer
unique
potential
engineer
multi-scale
living
constructs,
with
cellular
microenvironments
formed
by
stem
cell
self-assembled
structures
embedded
in
customizable
bioprinted
geometries.
This
study
introduces
volumetric
bioprinting
of
complex
organoid-laden
which
capture
key
human
liver.
Volumetric
via
optical
tomography
shapes
gelatin
hydrogels
into
centimeter-scale
3D
under
20
s.
Optically
tuned
bioresins
enable
refractive
index
matching
specific
intracellular
structures,
countering
disruptive
impact
cell-mediated
light
scattering
on
printing
resolution.
layerless,
nozzle-free
technique
poses
no
harmful
mechanical
stresses
organoids,
resulting
superior
viability
morphology
preservation
post-printing.
Bioprinted
organoids
undergo
hepatocytic
differentiation
showing
albumin
synthesis,
liver-specific
enzyme
activity,
remarkably
acquired
native-like
polarization.
Organoids
within
low
stiffness
gelatins
(<2
kPa)
mathematically
defined
lattices
varying
degrees
pore
network
tortuosity,
cultured
perfusion.
These
act
as
metabolic
biofactories
ammonia
detoxification
can
be
enhanced
architectural
profile
constructs.
technology
opens
up
new
possibilities
for
regenerative
medicine
personalized
drug
testing.
Cell,
Год журнала:
2022,
Номер
185(15), С. 2756 - 2769
Опубликована: Июль 1, 2022
For
decades,
insight
into
fundamental
principles
of
human
biology
and
disease
has
been
obtained
primarily
by
experiments
in
animal
models.
While
this
allowed
researchers
to
understand
many
biological
processes
great
detail,
some
developmental
mechanisms
have
proven
difficult
study
due
inherent
species
differences.
The
advent
organoid
technology
more
than
10
years
ago
established
laboratory-grown
organ
tissues
as
an
additional
model
system
recapitulate
human-specific
aspects
biology.
use
3D
organoids,
well
other
advances
single-cell
technologies,
revealed
unprecedented
insights
mechanisms,
especially
those
that
distinguish
humans
from
species.
This
review
highlights
novel
with
a
focus
on
how
generated
better
understanding
development
disease.
Journal of Hepatology,
Год журнала:
2022,
Номер
77(4), С. 1109 - 1123
Опубликована: Май 21, 2022
The
hepatitis
E
virus
(HEV)
was
initially
thought
to
exclusively
cause
acute
hepatitis.
However,
the
first
diagnosis
of
chronic
in
transplant
recipients
2008
profoundly
changed
our
understanding
this
pathogen.
We
have
now
begun
understand
that
specific
HEV
genotypes
can
infection
certain
immunocompromised
populations.
Over
past
decade,
dedicated
clinical
and
experimental
research
has
substantiated
knowledge
on
epidemiology,
transmission
routes,
pathophysiological
mechanisms,
diagnosis,
features
treatment
infection.
Nevertheless,
many
gaps
major
challenges
remain,
particularly
regarding
translation
into
disease
prevention
improvement
outcomes.
This
article
aims
highlight
latest
developments
management
E.
More
importantly,
we
attempt
identify
discuss
strategies
for
further
advancing
both
patient
care.
Cell stem cell,
Год журнала:
2023,
Номер
30(5), С. 571 - 591
Опубликована: Май 1, 2023
Human
pluripotent
stem
cells
(hPSCs)
and
three-dimensional
organoids
have
ushered
in
a
new
era
for
disease
modeling
drug
discovery.
Over
the
past
decade,
significant
progress
has
been
deriving
functional
from
hPSCs,
which
applied
to
recapitulate
phenotypes.
In
addition,
these
advancements
extended
application
of
hPSCs
screening
clinical-trial
safety
evaluations.
This
review
provides
an
overview
achievements
challenges
using
hPSC-derived
conduct
relevant
high-throughput,
high-contentscreens
evaluation.
These
studies
greatly
enhanced
our
knowledge
toolbox
precision
medicine.
Developmental Cell,
Год журнала:
2023,
Номер
58(12), С. 1106 - 1121.e7
Опубликована: Май 5, 2023
The
broad
research
use
of
organoids
from
high-grade
serous
ovarian
cancer
(HGSC)
has
been
hampered
by
low
culture
success
rates
and
limited
availability
fresh
tumor
material.
Here,
we
describe
a
method
for
generation
long-term
expansion
HGSC
with
efficacy
markedly
improved
over
previous
reports
(53%
vs.
23%-38%).
We
established
cryopreserved
material,
demonstrating
the
feasibility
using
viably
biobanked
tissue
organoid
derivation.
Genomic,
histologic,
single-cell
transcriptomic
analyses
revealed
that
recapitulated
genetic
phenotypic
features
original
tumors.
Organoid
drug
responses
correlated
clinical
treatment
outcomes,
although
in
conditions-dependent
manner
only
maintained
human
plasma-like
medium
(HPLM).
Organoids
consenting
patients
are
available
to
community
through
public
biobank
genomic
data
explorable
an
interactive
online
tool.
Taken
together,
this
resource
facilitates
application
basic
translational
research.